All In Biotech

Free tool

FAERS Monitor: Rytelo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217779 or its brand name (Rytelo, Imetelstat Sodium). Reports on generic versions are filed under their own applications.

Reports

186

Serious

103

55% of reports

Hospitalization

36

Death reported

11

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • platelet count decreased29
  • haemoglobin decreased27
  • thrombocytopenia24
  • cytopenia20
  • neutropenia17
  • neutrophil count decreased11
  • white blood cell count decreased10
  • infusion related reaction9
  • death8
  • dyspnoea7
  • pancytopenia7
  • drug ineffective6
  • fatigue5
  • full blood count decreased5
  • intercepted product preparation error5

Reports by year received

View as table
YearReports
202441
2025113
202632

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,973 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cytopeniaSignal20185.0122.23,475
intercepted product preparation errorSignal546.019.4177
platelet count decreasedSignal2930.822.0810
neutrophil count decreasedSignal1130.517.2286
haemoglobin decreasedSignal2729.721.0725
full blood count decreasedSignal528.111.8105
thrombocytopeniaSignal2424.316.7515
infusion related reactionSignal915.48.1107
pancytopeniaSignal714.26.873
neutropeniaSignal1714.19.0196
white blood cell count decreasedSignal1010.45.777
dyspnoea71.40.70
death81.10.50
fatigue50.70.30
drug ineffective60.50.22

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.